Arg413

Site Information
GMSVGQGrGKRRRLE SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 8093010

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 )
Relevant cell line - cell type - tissue:	'brain, embryonic' ( 15 ) , brain ( 1 , 2 , 3 , 4 , 14 ) , heart ( 16 ) , kidney ( 7 , 9 ) , liver ( 17 ) , lung ( 8 , 10 ) , PYS-2 (epithelial) ( 6 )

References
1	Guo A, et al. (2014) Immunoaffinity enrichment and mass spectrometry analysis of protein methylation. Mol Cell Proteomics 13, 372-87 24129315 Curated Info
2	Guo A (2013) CST Curation Set: 18334; Year: ; Biosample/Treatment: tissue, brain/-; Disease: -; SILAC: -; Curated Info
3	Guo A (2013) CST Curation Set: 18335; Year: ; Biosample/Treatment: tissue, brain/-; Disease: -; SILAC: -; Curated Info
4	Guo A (2013) CST Curation Set: 18337; Year: ; Biosample/Treatment: tissue, brain/-; Disease: -; SILAC: -; Curated Info
5	Zhou J (2010) CST Curation Set: 9110; Year: 2010; Biosample/Treatment: cell line, ES J1/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
6	Zhou J (2010) CST Curation Set: 9115; Year: 2010; Biosample/Treatment: cell line, PY2/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
7	Zhou J (2009) CST Curation Set: 7948; Year: 2009; Biosample/Treatment: tissue, kidney/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
8	Zhou J (2009) CST Curation Set: 7946; Year: 2009; Biosample/Treatment: tissue, lung/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
9	Zhou J (2009) CST Curation Set: 7947; Year: 2009; Biosample/Treatment: tissue, kidney/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
10	Zhou J (2009) CST Curation Set: 7945; Year: 2009; Biosample/Treatment: tissue, lung/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
11	Rikova K (2008) CST Curation Set: 4939; Year: 2008; Biosample/Treatment: cell line, Dana Farber-S1/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
12	Rikova K (2008) CST Curation Set: 4937; Year: 2008; Biosample/Treatment: cell line, Dana Farber-L1/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
13	Rikova K (2008) CST Curation Set: 4938; Year: 2008; Biosample/Treatment: cell line, Dana Farber-L2/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
14	Zhou J (2008) CST Curation Set: 3811; Year: 2008; Biosample/Treatment: tissue, brain/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
15	Zhou J (2008) CST Curation Set: 3812; Year: 2008; Biosample/Treatment: tissue, brain, embryonic/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
16	Zhou J (2008) CST Curation Set: 3813; Year: 2008; Biosample/Treatment: tissue, heart/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
17	Zhou J (2008) CST Curation Set: 3814; Year: 2008; Biosample/Treatment: tissue, liver/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info